Explore expert articles, in-depth analysis and stay informed with the latest in virology from Advanced Virology.
Modern biomedical research depends on a simple economic principle: laboratories purchase standardized reagents whenever specialized manufacturers can produce them more efficiently than individual research groups.
Every year, preclinical research in the United States wastes an estimated $28 billion on irreproducible studies...
Whether developing vaccines, testing antivirals, or building diagnostic assays, success depends heavily on the fidelity of the virus stocks used during R&D.
In recent years, reverse genetics has emerged as a more precise and powerful alternative to serial passaging, offering a range of advantages in the production of virus stocks.
Utilizing Reporter Viruses in Antiviral Drug Discovery Antiviral drug discovery is a cornerstone of modern infectious disease research. Rapid screening of compound libraries and accurate quantitation of virus replication are...
Since the establishment of virology over a century ago, serial passaging of virus stocks has been used to study viruses and develop products such as vaccines for medical use.
Advanced Virology Inc. is seeking an experienced virologist to support production of high-quality viral products for use in downstream R&D and product manufacturing.
In virology, chimeric viruses are powerful tools that combine genetic elements from two or more viruses to create a hybrid organism. These engineered viruses play an important role in advancing...
This technology doesn't just reveal what's dominant; it shows what's hiding beneath the surface & in virology those hidden variants can make all the difference.
Subscribe to our newsletter for industry insights and research updates.
Subscribe to our newsletter for industry
insights and research updates.